PeptidePros

Methodology

How PeptidePros evaluates evidence, vendors, and protocol paths.

The site is built for research decision support, not peptide sales. Every content template should make uncertainty, commercial incentives, and safety boundaries visible before a user starts the quiz, opens a vendor link, or buys a protocol PDF.

Evidence tiers

  • Compound pages weigh approved-drug status, human data, preclinical depth, regulatory posture, and uncertainty.
  • Low-evidence compounds are not presented as proven therapies, even when vendor demand is high.
  • FDA, WADA, and primary literature sources are prioritized over anecdotal marketplace claims.

Vendor scoring

  • Vendor rankings emphasize documentation strength, COA visibility, product-page specificity, reputation signals, shipping clarity, and support visibility.
  • Affiliate status can be disclosed near CTAs but does not override documentation, regulatory, or product-match quality.
  • Exact product-page links are treated as stronger than broad vendor homepage routing.

COA and quality checks

  • Useful COAs should make identity, purity, lot, method, date, and lab context easy to verify.
  • PeptidePros flags whether COA access is public, portal-based, request-based, label-based, or unknown.
  • COA presence is not treated as proof of suitability, safety, legality, or medical appropriateness.

Calculator assumptions

  • Tools perform arithmetic and comparison support; they are not dosing instructions.
  • Users must verify vial labels, concentration, volume, sterility, and clinician guidance independently.
  • Calculator pages route users back to peptide profiles, vendors, and the quiz so math is not divorced from risk context.

Affiliate policy

  • PeptidePros may earn commissions from some outbound vendor links.
  • Affiliate links are routed through blocked `/out/*` paths so they do not become indexable SEO pages.
  • Commercial pages should explain why a vendor appears before sending users off site.

RUO and medical boundaries

  • PeptidePros does not sell peptides, prescribe peptides, or provide medical advice.
  • Research-use-only and non-approved compounds require conservative language and clear warnings.
  • Competitive athletes should treat WADA risk as a primary filter, not a footnote.
Take the quiz with this context